Omada Health, Inc. reporting persons led by Andreessen Horowitz files an amendment to a Schedule 13G/A disclosing beneficial ownership stakes as of March 31, 2026. The filing lists aggregate holdings for affiliated entities and individuals, including 2,105,300 shares held by Andreessen Horowitz Fund IV, 201,984 shares held by AH Parallel Fund IV, and individual indirect holdings for Marc L. Andreessen and Benjamin A. Horowitz.
The percentages are calculated using 59,240,000 shares outstanding as of March 31, 2026, with reported percentages of 3.6%, 0.3%, 3.9%, and 4.2% for specific reporting persons. Ownership disclosures include descriptions of voting and dispositive powers and entity relationships; the Reporting Persons disclaim status as a "group."
Positive
None.
Negative
None.
Insights
Amendment clarifies affiliated ownership and voting/dispositive powers.
The filing itemizes beneficial ownership across related Andreessen Horowitz entities and individuals, tying specific share counts to entities (e.g., 2,105,300 shares for Andreessen Horowitz Fund IV) and disclosing voting/dispositive power allocations. It expressly disclaims formation of a "group."
Dependencies include the limited partnership and LLC governance provisions cited as affecting rights to dividends or sale proceeds. Future filings or portfolio changes would alter these percentages; timing for any change is not provided in the excerpt.
Key Figures
Shares outstanding:59,240,000 sharesAH Fund IV holdings:2,105,300 sharesAH Parallel IV holdings:201,984 shares+3 more
6 metrics
Shares outstanding59,240,000 sharesas of March 31, 2026 (per issuer Form 10-Q)
AH Fund IV holdings2,105,300 sharesheld by Andreessen Horowitz Fund IV as of March 31, 2026
AH Parallel IV holdings201,984 sharesheld by AH Parallel Fund IV as of March 31, 2026
Marc L. Andreessen holdings2,307,284 sharesbeneficial ownership reported as of March 31, 2026
Benjamin A. Horowitz holdings2,461,709 sharesbeneficial ownership reported as of March 31, 2026
Percent of class (example)3.6%percentage tied to 2,105,300 shares based on 59,240,000 outstanding
Key Terms
beneficially owned, sole voting power / shared voting power, Schedule 13G/A, dispositive power
4 terms
beneficially ownedregulatory
"Row 9 of each Reporting Person's cover page to this sets forth the aggregate number"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole voting power / shared voting powerregulatory
"Row 5 ... sets forth the sole power to vote ... Row 6 ... sets forth the shared power to vote"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
dispositive powerregulatory
"Row 7 ... sets forth the sole power to dispose ... Row 8 ... sets forth the shared power to dispose"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 2)
Omada Health, Inc.
(Name of Issuer)
Common Stock, $0.001 par value
(Title of Class of Securities)
68170A108
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
68170A108
1
Names of Reporting Persons
Andreessen Horowitz Fund IV, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
2,105,300.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
2,105,300.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
2,105,300.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
3.6 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
68170A108
1
Names of Reporting Persons
AH Equity Partners IV, L.L.C.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
2,105,300.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
2,105,300.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
2,105,300.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
3.6 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
68170A108
1
Names of Reporting Persons
AH Parallel Fund IV, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
201,984.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
201,984.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
201,984.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.3 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
68170A108
1
Names of Reporting Persons
AH Equity Partners IV (Parallel), L.L.C.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
201,984.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
201,984.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
201,984.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.3 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
68170A108
1
Names of Reporting Persons
Marc L. Andreessen
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
2,307,284.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
2,307,284.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
2,307,284.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
3.9 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
CUSIP Number(s):
68170A108
1
Names of Reporting Persons
Benjamin A. Horowitz
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
2,461,709.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
2,461,709.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
2,461,709.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.2 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Omada Health, Inc.
(b)
Address of issuer's principal executive offices:
611 Gateway Blvd, Suite 120, South San Francisco, CA, 94080.
Item 2.
(a)
Name of person filing:
The names of the persons filing this report (collectively, the "Reporting Persons") are:
Andreessen Horowitz Fund IV, L.P. ("AH IV")
AH Equity Partners IV, L.L.C. ("AH Equity IV")
AH Parallel Fund IV, L.P. ("AH Parallel IV")
AH Equity Partners IV (Parallel), L.L.C. ("AH Equity Parallel IV")
Marc L. Andreessen ("Andreessen")
Benjamin A. Horowitz ("Horowitz")
The Reporting Persons expressly disclaim status as a "group" for purposes of this Schedule 13G.
(b)
Address or principal business office or, if none, residence:
The address for each of the Reporting Persons is:
Andreessen Horowitz
2865 Sand Hill Road, Suite 101
Menlo Park, CA 94025
(c)
Citizenship:
AH IV Delaware
AH Equity IV Delaware
AH Parallel IV Delaware
AH Equity Parallel IV Delaware
Andreessen United States
Horowitz United States
(d)
Title of class of securities:
Common Stock, $0.001 par value
(e)
CUSIP No.:
68170A108
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
Row 9 of each Reporting Person's cover page to this Schedule 13G sets forth the aggregate number of shares of common stock of the Issuer beneficially owned by such Reporting Person as of March 31, 2026 and is incorporated by reference.
The Reporting Persons' ownership of the Issuer's securities includes (i) 2,105,300 shares of common stock directly held by AH IV for itself and as nominee of Andreessen Horowitz Fund IV-A, L.P., Andreessen Horowitz Fund IV-B, L.P. and Andreessen Horowitz Fund IV-Q, L.P.; (ii) 201,984 shares of common stock directly held by AH Parallel IV for itself and as nominee of AH Parallel Fund IV-A, L.P., AH Parallel Fund IV-B, L.P., and AH Parallel Fund IV-Q, L.P; and (iii) 154,425 shares of common stock directly held by the 1997 Horowitz Family Trust.
AH Equity IV is the general partner of AH IV and may be deemed to have sole power to vote and sole power to dispose of the shares of the Issuer held of record by AH IV for itself and as nominee of Andreessen Horowitz Fund IV-A, L.P., Andreessen Horowitz Fund IV-B, L.P. and Andreessen Horowitz Fund IV-Q, L.P. Andreessen and Horowitz are managing members of AH Equity IV and may be deemed to have shared voting and shared dispositive power over the shares held of record by AH IV for itself and as nominee.
AH Equity Parallel IV is the general partner of AH Parallel IV and may be deemed to have sole power to vote and sole power to dispose of shares of the Issuer held of record by AH Parallel IV for itself and as nominee of AH Parallel Fund IV-A, L.P., AH Parallel Fund IV-B, L.P., and AH Parallel Fund IV-Q, L.P. Andreessen and Horowitz are managing members of AH Equity Parallel IV and may be deemed to have shared voting and shared dispositive power over the shares held of record by AH Parallel IV for itself and as nominee.
Horowitz is a trustee of the 1997 Horowitz Family Trust and may be deemed to have shared voting and shared dispositive power over the shares held of record by the 1997 Horowitz Family Trust.
(b)
Percent of class:
Row 11 of each Reporting Person's cover page to this Schedule 13G sets forth the percentages of the shares of common stock of the Issuer beneficially owned by such Reporting Person as of March 31, 2026 and is incorporated by reference. The percentage set forth in each row 11 is based upon 59,240,000 shares of common stock outstanding as of March 31, 2026, as disclosed in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the "SEC") on May 8, 2026.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Row 5 of each Reporting Person's cover page to this Schedule 13G sets forth the sole power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Person as of March 31, 2026 and is incorporated by reference.
(ii) Shared power to vote or to direct the vote:
Row 6 of each Reporting Person's cover page to this Schedule 13G sets forth the shared power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Person as of March 31, 2026 and is incorporated by reference.
(iii) Sole power to dispose or to direct the disposition of:
Row 7 of each Reporting Person's cover page to this Schedule 13G sets forth the sole power to dispose or to direct the disposition of securities of the Issuer beneficially owned by such Reporting Person as of March 31, 2026 and is incorporated by reference.
(iv) Shared power to dispose or to direct the disposition of:
Row 8 of each Reporting Person's cover page to this Schedule 13G sets forth the shared power to dispose or to direct the disposition of securities of the Issuer beneficially owned by such Reporting Person as of March 31, 2026 and is incorporated by reference.
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
Under certain circumstances set forth in the limited partnership agreements of each of AH IV and AH Parallel IV and the limited liability company agreements of AH Equity IV and AH Equity Parallel IV, the general partner and limited partners or members, as the case may be, of each of such entities may be deemed to have the right to receive dividends from, or the proceeds from, the sale of shares of the Issuer owned by each such entity of which they are a partner or a member, as the case may be.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
Not Applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Andreessen Horowitz Fund IV, L.P.
Signature:
/s/ Phil Hathaway
Name/Title:
By AH Equity Partners IV, L.L.C., Its General Partner, By Phil Hathaway, Chief Operating Officer (See Note 1)
Date:
05/15/2026
AH Equity Partners IV, L.L.C.
Signature:
/s/ Phil Hathaway
Name/Title:
By Phil Hathaway, Chief Operating Officer
Date:
05/15/2026
AH Parallel Fund IV, L.P.
Signature:
/s/ Phil Hathaway
Name/Title:
By AH Equity Partners IV (Parallel), L.L.C., Its General Partner, By Phil Hathaway, Chief Operating Officer (See Note 2)
Date:
05/15/2026
AH Equity Partners IV (Parallel), L.L.C.
Signature:
/s/ Phil Hathaway
Name/Title:
By Phil Hathaway, Chief Operating Officer
Date:
05/15/2026
Marc L. Andreessen
Signature:
/s/ Phil Hathaway
Name/Title:
By Phil Hathaway, Attorney-in-Fact
Date:
05/15/2026
Benjamin A. Horowitz
Signature:
/s/ Phil Hathaway
Name/Title:
By Phil Hathaway, Attorney-in-Fact
Date:
05/15/2026
Comments accompanying signature: Note 1: Andreessen Horowitz Fund IV, L.P. for itself and as nominee for Andreessen Horowitz Fund IV-A, L.P., Andreessen Horowitz Fund IV-B, L.P. and Andreessen Horowitz Fund IV-Q, L.P.
Note 2: AH Parallel Fund IV, L.P. for itself and as nominee for AH Parallel Fund IV-A, L.P., AH Parallel Fund IV-B L.P. and AH Parallel Fund IV-Q, L.P.
Exhibit Information
Exhibit 24.1 Power of Attorney for Marc L. Andreessen, dated June 23, 2023 (incorporated by reference to Exhibit 24.1 to the Reporting Persons' Schedule 13G filed with the SEC on August 14, 2025).
Exhibit 24.2 Power of Attorney for Benjamin A. Horowitz, dated June 22, 2023 (incorporated by reference to Exhibit 24.2 to the Reporting Persons' Schedule 13G filed with the SEC on August 14, 2025).
Exhibit 99.1 Joint Filing Agreement (incorporated by reference to Exhibit 99.1 to the Reporting Persons' Schedule 13G filed with the SEC on August 14, 2025).
What stake does Andreessen Horowitz report in OMDA?
Andreessen Horowitz Fund IV reports beneficial ownership of 2,105,300 shares as of March 31, 2026. This count appears on the cover rows and the filing states percentages based on 59,240,000 shares outstanding on that date from the issuer's Form 10-Q.
How much of Omada does Marc L. Andreessen and Ben Horowitz each control?
Marc L. Andreessen is shown with 2,307,284 shares (3.9%) and Benjamin A. Horowitz with 2,461,709 shares (4.2%). The filing attributes these figures to shared voting and dispositive power via affiliated entities and trusts as disclosed.
What outstanding share count does the filing use to calculate percentages?
The filing uses 59,240,000 shares outstanding as of March 31, 2026 to compute percentages. That outstanding figure is stated as disclosed in the issuer's Form 10-Q referenced in the amendment.
Does the filing state who receives sale proceeds or dividends?
The filing notes limited partnership and LLC agreement provisions that may affect rights to dividends or sale proceeds but does not identify any other person as having a separate right to proceeds. Specific payee assignments are not detailed in the excerpt.
Do the Reporting Persons act as a voting group under the filing?
The Reporting Persons expressly disclaim status as a 'group' for purposes of the filing. The amendment nevertheless describes shared and sole voting/dispositive powers across affiliated entities and individuals.
